Tyrosine kinase 3D structures
From Proteopedia
(Difference between revisions)
| Line 113: | Line 113: | ||
**[[7nx4]] - hTK TG+EGF-like domain<br /> | **[[7nx4]] - hTK TG+EGF-like domain<br /> | ||
**[[7nx3]] - hTK TG+EGF-like domain + antibody<br /> | **[[7nx3]] - hTK TG+EGF-like domain + antibody<br /> | ||
| - | **[[2xb7]], [[2xba]], [[3aox]], [[5imx]], [[5kz0]], [[4ccb]], [[4ccu]], [[4cli]], [[4cmo]], [[4cmt]], [[4cmu]], [[4cnh]], [[4ctb]], [[4ctc | + | **[[2xb7]], [[2xba]], [[3aox]], [[5imx]], [[5kz0]], [[4ccb]], [[4ccu]], [[4cli]], [[4cmo]], [[4cmt]], [[4cmu]], [[4cnh]], [[4ctb]], [[4ctc]], [[6edl]], [[6ebw]], [[6e0r]], [[7btt]], [[7jy4]], [[7jyr]], [[7jys]], [[7jyt]] - hTK kinase domain + inhibitor<br /> |
**[[4dce]], [[4fob]], [[4foc]], [[4fod]], [[4fny]], [[4fnz]], [[4joa]], [[4mkc]], [[4z55]], [[5iug]], [[5iuh]], [[5iui]], [[4cd0]], [[4clj]] - hTK kinase domain (mutant) + inhibitor<br /> | **[[4dce]], [[4fob]], [[4foc]], [[4fod]], [[4fny]], [[4fnz]], [[4joa]], [[4mkc]], [[4z55]], [[5iug]], [[5iuh]], [[5iui]], [[4cd0]], [[4clj]] - hTK kinase domain (mutant) + inhibitor<br /> | ||
| - | **[[2xp2]], [[ | + | **[[2xp2]], [[6mx8]], [[5fto]], [[5ftq]] - hTK kinase domain + cancer drug<br /> |
**[[2yfx]], [[4anq]], [[4ans]], [[5aaa]], [[5aab]], [[5aac]], [[5a9u]], [[5aa8]], [[5aa9]] - hTK kinase domain (mutant) + cancer drug<br /> | **[[2yfx]], [[4anq]], [[4ans]], [[5aaa]], [[5aab]], [[5aac]], [[5a9u]], [[5aa8]], [[5aa9]] - hTK kinase domain (mutant) + cancer drug<br /> | ||
**[[7n00]], [[7nwz]]] - hTK kinase domain (mutant) + AUG-alpha<br /> | **[[7n00]], [[7nwz]]] - hTK kinase domain (mutant) + AUG-alpha<br /> | ||
Revision as of 10:33, 15 June 2022
3D structures of tyrosine kinase
Updated on 15-June-2022 - For a general description of the protein see Tyrosine kinase
- hTK Ret kinase domain + cancer drug
